|
|
Gene Expression Reagents MarketsPublished by: Trimark Publications Published: Apr. 1, 2007 - 113 Pages Table of Contents1. Overview 1.1 Objectives of the Report 1.2 Methodology 1.3 Scope of the Report 1.4 Executive Summary 2. Gene Expression 2.1 The Genomics Revolution 2.2 Basic Principles of Gene Expression 2.3.1 Quantitative Real-Time PCR (qRT-PCR) 2.3.2 PCR Labeling Chemistries 2.3.3 TaqMan® Probes 2.3.4 SYBR® Green 2.4 Microarray Technology 2.5 Microarray Target Preparation and Hybridization 2.6 RNA Sample Preparation and Assessment 3. Gene Expression Reagents 3.1 Kit Format vs. Home-Brew Assays 3.2 Whole Product Solutions 3.3 Emerging Technologies 4. Market Environment 4.1 Institutional and Government Budgeting 4.2 Worldwide Investment in Genomics Technologies and Research 4.3 Industry Consolidation and Acquisitions 5. Market Drivers 5.1 Improved Assay Performance 5.2 Cost Effective Systems 5.3 Automation 5.4 Bioinformatics Solutions 6. Worldwide Market for Gene Expression Reagents 6.1 Life Science Research 6.2 Drug Discovery and Development, Molecular Diagnostics 6.3 Commercial Production 6.4 Gene Expression Market Size 6.4.1 Real-Time PCR Revenue 6.4.2 Commercial Microarray Revenue 6.4.3 RNA Sample Preparation Revenue 6.5 Gene Expression Reagent Market by Region 6.6 Users of Gene Expression Products 6.6.1 Core Laboratories 6.6.2 Consortia 6.6.3 Pharmaceutical and Biotechnology Companies 6.7 Affiliation 6.8 Job Function and Decision Makers 7. Key Applications 7.1 BioMarker Identification and Pharmacogenomics 7.2 Toxicogenomics 7.3 Molecular Diagnostics 8. Vendor and Product Selection 8.1 Product Adoption 8.2 Drivers for Product Switching 9. Leading Vendors 10. Marketing Strategies 10.1 e-Marketing and e-Commerce 10.2 Catalog 38 10.3 On-Site Cabinet Programs 11. Pricing Strategies 11.1 Price Elasticity 11.2 Strategies 12. Distribution Channels 13. Competitive Situation 14. Opportunities 15. Market Strategy Profiles, Leading and Selected Vendors 15.1 Applied Biosystems 15.1.1 Applera Corporation—Corporate History and Structure 15.1.2 Molecular Biology Technology and Products 15.1.3 Acquisitions, Partnerships and Collaborations, 2006 15.1.4 Product Portfolio Summary 15.1.5 Real-Time PCR/Genomics Products and Consumables 15.1.6 Real-Time PCR/Genomics New Product Introductions, 2006 15.1.7 End-Users 15.1.8 Distribution Channels 15.1.9 Competition—Gene Expression Products 15.1.10 Competitive Analysis 15.1.11 Business Model 15.2 Affymetrix 15.2.1 Corporate History and Structure 15.2.2 Technology 15.2.3 Partnerships and Collaborations 15.2.4 Product Portfolio Summary 15.2.5 Complementary Services 15.2.6 New Product Introductions 15.2.7 End-Users 15.2.8 Distribution Channels 15.2.9 Competition 15.2.10 Competitive Analysis 15.2.11 Business Model 15.3 Invitrogen 15.3.1 Corporate History and Structure 15.3.2 Technology 15.3.3 Acquisitions 15.3.4 Partnerships and Collaborations 15.3.5 Product Profile Summary 15.3.6 Gene Expression Product Portfolio 15.3.7 New Product Introductions 15.3.8 End-Users 15.3.9 Distribution Channels 15.3.10 Competition 15.3.11 Competitive Analysis 15.3.12 Business Model 15.4 Qiagen 15.4.1 Corporate History and Structure 15.4.2 Technology 15.4.3 Acquisitions, Partnerships and Collaborations 15.4.4 Collaborations and Partnerships 15.4.5 Product Portfolio Summary 15.4.6 Complementary Services 15.4.7 New Product Introductions 15.4.8 End-Users 15.4.9 Distribution Channels 15.4.10 Competition 15.4.11 Competitive Analysis 15.4.12 Business Model 15.5 GE Healthcare (Formerly Amersham Biosciences) 15.5.1 Corporate History and Structure 15.5.2 Technology 15.5.3 Product Portfolio Summary 15.5.4 Complementary Services 15.5.5 Genomics New Product Introductions 15.5.6 Amersham Biosciences End-Users 15.5.7 Distribution Channels 15.5.8 Competition 15.5.9 Competitive Analysis 15.5.10 Business Model 15.6 Stratagene 15.6.1 Corporate History and Structure 15.6.2 Technology 15.6.3 Acquisitions, Collaborations, Alliances and Partnerships 15.6.4 Product Portfolio Summary—Research Products Division 15.6.5 New Product Introductions 15.6.6 Complementary Services 15.6.7 End-Users 15.6.8 Distribution Channels 15.6.9 Competition 15.6.10 Competitive Analysis 15.6.11 Business Model Appendix I: Leading Vendor’s Gene Expression Products Appendix II: Gene Expression Product Groups Appendix III: Companies Offering Gene Expression Products LIST OF FIGURES Figure 2.1: Gene Expression Process Figure 2.2: qRT-PCR Workflow Figure 2.3: Microarray Workflow Figure 6.1: Gene Expression Market by Region Figure 6.2: Researchers Using Gene Expression Technologies Worldwide, 2005 Figure 6.3: Distribution of Laboratory Workers by Organization in North America Figure 6.4: Laboratory Job Function Figure 6.5: Product Selection and Purchasing Decision Makers LIST OF TABLES Table 5.1: Microarray Analysis Cost per Sample Table 5.2: Cost of qRT-PCR Research Reagents and Systems Table 6.1: Five-Year Forecast—Gene Expression Reagents, Instruments Table 6.2: RNA Sample Preparation Revenue Table 6.3: Forecasted Annual Revenue—qRT-PCR, 2005-2010 Table 6.4: Forecasted Annual Revenue—Commercial Microarrays, Reagents, Instruments, 2005-2010 Table 6.5: Forecasted Annual Revenue—Gene Expression Reagents, Instruments, 2005-2010 Table 6.6: Forecasted Annual Revenue—RNA Sample Preparation, 2005-2010 Table 6.7: Projected Revenue Growth of Microarrays and Related Products Table 6.8: Major Players’ Distribution of Revenue by Region, 2005 Table 6.9: Decision Makers Profile Table 9.1: Major Vendors—Gene Expression Reagents and RNA Sample Preparation Table 9.2: Vendors’ Key Statistics, 2005 Table 9.3: Vendors’ Technology and Products Table 11.1: RNA Sample Preparation—Vendors Prices Table 11.2: qPCR Kits—Vendor’s Prices Table 11.3: Reverse Transcriptase—Vendor’s Prices Table 12.1: Distribution Channels Table 15.1: Applied Biosystems Revenue, 2005 Table 15.2: Affymetrix Revenue, 2005 Table 15.3: Invitrogen Revenue, 2005 Table 15.4: Qiagen Revenue, 2005 Table 15.5: GE Healthcare Revenue, 2005 Table 15.6: Stratagene Revenue, 2005 AbstractThe area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments that are performed to determine whether a particular gene is expressed—i.e., present—and in some cases at what levels, in a biological sample. The purpose of this TriMark Publications report is to describe the specific segments of the global gene expression reagents market. Within this area, the study covers those segments that are highly active in terms of innovation and growth. Specifically, this review examines the markets for gene expression reagents and small lab equipment all the way up to highly automated platforms. Emphasis is on those companies that are actively developing and marketing gene expression reagents for genomics research in the academic sector and the pharmaceutical, bioscience industry. This study concentrates on the laboratory reagent market segment and the companion gene expression reagents sector in the U.S. and around the world that use materials for genetic research. Particular attention is paid to those areas of the gene expression reagents sector that are showing the greatest growth or the most innovation.
|
|
|||
|
About MarketResearch.com
|
||||